Liminal BioSciences Inc. Common Shares
LMNL
LMNL was delisted on the 25th of September, 2023.
8 hedge funds and large institutions have $105K invested in Liminal BioSciences Inc. Common Shares in 2023 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 5 reducing their positions, and 7 closing their positions.
46% more capital invested
Capital invested by funds: $71.6K → $105K (+$33K)
43% less funds holding
Funds holding: 14 → 8 (-6)
80% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 5
86% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$65.3K |
| 2 |
FDCDDQ
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
|
+$388 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$13K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
-$7K |
| 3 |
Millennium Management
New York
|
-$4K |
| 4 |
IA
IFP Advisors
Tampa,
Florida
|
-$1K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$901 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $53.7K | +$65.3K | +14,133 | New |
|
2
National Bank of Canada
Montreal,
Quebec, Canada
| $34.2K | -$74 | -16 | -0.2% |
|
|
FDCDDQ
3
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| $12.6K | +$388 | +84 | +3% |
|
4
Royal Bank of Canada
Toronto,
Ontario, Canada
| $2K | -$65 | -14 | -3% |
|
|
ECM
5
Estabrook Capital Management
New York
| $1.9K | – | – | – |
|
|
6
UBS Group
Zurich,
Switzerland
| $182 | -$901 | -195 | -80% |
|
|
TWC
7
TD Waterhouse Canada
Toronto,
Ontario, Canada
| $15 | -$14 | -3 | -50% |
|
|
8
Renaissance Technologies
New York
| – | -$13K | -3,850 | Closed |
|
|
9
Geode Capital Management
Boston,
Massachusetts
| – | -$7K | -2,274 | Closed |
|
|
10
Millennium Management
New York
| – | -$4K | -1,135 | Closed |
|
11
Group One Trading
Chicago,
Illinois
| – | -$33 | -10 | Closed |
|
12
Morgan Stanley
New York
| – | -$20 | -6 | Closed |
|
|
IA
13
IFP Advisors
Tampa,
Florida
| – | -$1K | -1 | Closed |
|
|
TCM
14
Tanaka Capital Management
New York
| – | -$5 | -1 | -50% |
|
LMNL Hedge Fund Activity: Q1 2023 in Review
8 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in Liminal BioSciences Inc. Common Shares (LMNL) for Q1 2023, worth a combined $105K — up 46% from $71.6K a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of LMNL and 1 opened new positions — a net loss of 6 holders — while 5 trimmed existing stakes and 1 added.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $65.3K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $13K sold.
- 8 institutional investors held Liminal BioSciences Inc. Common Shares (LMNL) as of Q1 2023, down from 14 in Q4 2022.
- Funds reported $105K of Liminal BioSciences Inc. Common Shares stock for Q1 2023, up 46% quarter-over-quarter.
- 1 fund opened new Liminal BioSciences Inc. Common Shares positions in Q1 2023 and 7 closed out, a net change of -6 holders.
- The largest Liminal BioSciences Inc. Common Shares buyer in Q1 2023 was Susquehanna International Group, an estimated $65.3K added.
- The largest Liminal BioSciences Inc. Common Shares seller in Q1 2023 was Renaissance Technologies, an estimated $13K sold.
Based on aggregated 13F filings for Q1 2023.